Type 2 Diabetes

Next Page »

Type 2 Diabetes Drug May Cut Lung Cancer Risk

Wednesday, May 25th, 2011 by Chris Frankie

Metformin, a common Type 2 diabetes drug, may help prevent smokers from developing lung cancer (more…)

Diabetes Rising Among Cats and Dogs

Wednesday, May 25th, 2011 by Chris Frankie

A new study from Banfield Pet Hospital, a chain of pet hospitals, says that the number of dogs and cats in America with diabetes is growing. (more…)

Avandia to Be Pulled from Drugstore Shelves

Wednesday, May 25th, 2011 by Chris Frankie

Controversial Type 2 diabetes drug Avandia is being pulled from retail pharmacies starting in November (more…)

Study Links Diabetes, Autism

Thursday, May 12th, 2011 by Chris Frankie

A new study suggests that women with Type 2 diabetes, high blood pressure or are obese run an increased risk of giving birth to a child with autism (more…)

FDA Approves New Type 2 Drug Tradjenta

Thursday, May 12th, 2011 by Chris Frankie

The Food and Drug Administration has approved a new Type 2 diabetes Drug. It’s called Tradjenta and is being jointly marketed by Boehringer Ingelheim and Eli Lilly (more…)

Overweight Pregnant Women Given Diabetes Drugs to Cut Child’s Obesity Risk

Thursday, May 12th, 2011 by Chris Frankie

Overweight pregnant women are being given diabetes drugs in a new study to try and cut the chances of their offspring being obese (more…)

Type 2 Diabetes Partly Reversible: Researchers

Wednesday, April 27th, 2011 by Chris Frankie

Type 2 diabetes is partly reversible, according to researchers from the School of Medicine. (more…)

Don’t Just Blame the Diabetic

Wednesday, April 20th, 2011 by Chris Frankie

The vast majority of Americans assume that people with diabetes – both Type 1 and Type 2 – did something to bring the disease upon themselves (more…)

Study Finds Caffeine May Contribute to Type 2

Wednesday, April 20th, 2011 by Chris Frankie

A new study concludes that caffeine may contribute to the development of Type 2 diabetes (more…)

Sanofi Reports Positive Results from Experimental Type 2 Drug

Wednesday, April 13th, 2011 by Chris Frankie

Sanofi-Aventis said that lixisenatide, an experimental Type 2 diabetes drug, has been very successful in a late stage trial at helping patients reduce their blood sugar levels and lose weight (more…)